GlassScriptPhysician profile
Ksenija Kos
NPI 1265454987
$6,013.56
in general payments reported to CMS, 2019-2025
45 companies · $1,415 in 2025
The $1,415 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $107 · 2021: $24.57 · 2022: $106 · 2023: $706 · 2024: $3,004 · 2025: $1,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,006 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,005.85 |
| Education | $120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,559.92 | 2022-2025 | |
| Biogen, INC. | $580.24 | 2019-2025 | Tysabri, Vumerity, Tysabri |
| Lilly USA, LLC | $374.75 | 2022-2025 | Emgality, Kisunla, Amyvid |
| Emd Serono, INC. | $344.81 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $267.78 | 2024-2025 | Ponvory |
| Ucb, INC. | $266.86 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Novartis Pharmaceuticals Corporation | $250.32 | 2019-2025 | |
| Argenx US, INC. | $171.22 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Tg Therapeutics, INC. | $166.71 | 2024-2025 | |
| Genzyme Corporation | $160.23 | 2019-2024 | |
| Pfizer INC. | $139.19 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $121.21 | 2019-2024 | Ultomiris |
| Amgen INC. | $120.14 | 2019-2025 | |
| Genentech USA, INC. | $116.82 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Teva Pharmaceuticals USA, INC. | $111.46 | 2019-2025 | Austedo Xr, Austedo Xr |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ksenija Kos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.